Artivion (NYSE:AORT – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, May 4th. Analysts expect Artivion to post earnings of ($0.01) per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link. Artivion Stock […]
Artivion (NYSE:AORT – Get Rating) and iRhythm Technologies (NASDAQ:IRTC – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk. Profitability This table compares Artivion and iRhythm Technologies’ net margins, return […]
/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate.
Artivion, Inc. (NYSE:AORT – Get Rating) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 3,170,000 shares, a decline of 6.2% from the February 28th total of 3,380,000 shares. Approximately 8.3% of the shares of the stock are short sold. Based on an […]